ZURICH (Reuters) - Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis.
Ilaris inhibits interleukin-1 beta, excessive production of which plays a prominent role in certain inflammatory diseases, the company said.
The drug is the only approved treatment specifically for the condition that can be given as a monthly subcutaneous injection, Novartis said.
Ilaris is also approved in the European Union for the treatment of refractory gouty arthritis, Novartis said.
(Reporting by Zurich Newsroom)
Source: http://news.yahoo.com/u-approves-novartis-drug-ilaris-treat-childhood-arthritis-054737426.html
Illinois Lottery texas lottery Dell Levis Fireman Ed Allegiant Air Melissa Rycroft
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন